GNCA Overview
Upcoming Projects (GNCA)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (GNCA)
-
Don’t see a project related to the company you care about? Create your own!
Expired Projects (GNCA)
-
After Genocea's blistering stock move today, is the GEN-003 data enough for the company to shed its micro-cap status?
Ticker: GNCA
Execute By: Apr 08, 2016
Upcoming & Overdue Catalysts (GNCA)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (GNCA)
-
Genocea(GNCA) presents new Phase 1/2 data of GEN-009 Vaccine Immune Responses to ATLAS-selected Neoantigens in Cancer Patients
Ticker: GNCA
Occurred on: Jun 03, 2019 -
Genocea to Test GEN-003 Treatment for Genital Herpes Against Phase 3 Endpoints
Ticker: GNCA
Occurred on: Sep 29, 2016 -
Genocea Begins Dosing of Phase 2b GEN-003 for Genital Herpes Treatment
Ticker: GNCA
Occurred on: Jul 09, 2016 -
Phase 2 12-month data of GEN-003 for Herpes simplex virus type 2 (HSV-2) due 1Q 2016
Ticker: GNCA
Occurred on: Apr 05, 2016 -
Genocea (GNCA) Announces Top-Line Phase 2a Results for Universal Pneumococcal Vaccine Candidate GEN-004
Ticker: GNCA
Occurred on: Oct 19, 2015
Strategic Initiatives (GNCA)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
